Intuitive Surgical Inc. Receives FDA Clearance for Innovative Vessel Sealer Curved Instrument

Reuters
07-10
Intuitive Surgical Inc. Receives FDA Clearance for Innovative Vessel Sealer Curved Instrument

Intuitive Surgical Inc. has announced that the U.S. Food & Drug Administration (FDA) has granted clearance for its latest innovation, the Vessel Sealer Curved, for use with its multiport da Vinci systems. This advanced bipolar electrosurgical instrument is designed to enhance surgical precision through its unique curved tip, allowing for the sealing, cutting, grasping, and dissection of tissue. It is the first of Intuitive's advanced energy instruments to receive FDA clearance for the transection of lymphatic vessels. The Vessel Sealer Curved is approved for grasping and blunt dissection of tissue, bipolar coagulation, and mechanical transection of blood vessels up to 7mm in diameter, as well as lymphatic vessels and tissue bundles. However, it is not indicated for tubal sterilization or tubal coagulation for sterilization procedures. This clearance marks a significant milestone in Intuitive's 30-year journey in robotic-assisted technology aimed at improving patient outcomes and expanding access to minimally invasive care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intuitive Surgical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9492113-en) on July 10, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10